Contingencies and commitments

Notes
CSR report

Contractual obligations and commitments

We have certain purchase commitments principally with CRO subcontractors and certain collaboration partners.

On 31 March 2020, we had outstanding obligations for purchase commitments, which become due as follows:

(thousands of €)

Total

Less than
1 year

1 - 3 years

3 - 5 years

More than
5 years

Purchase commitments

266,330

192,869

66,291

6,912

258

In addition we have engaged a property developer for the construction of a building in Leiden.

At 31 March 2020, we were committed to leases which have not yet started. The total future cash outflows for leases that had not yet commenced were as follows:

(thousands of €)

Total

Less than
1 year

1 - 3 years

3 - 5 years

More than
5 years

Lease commitments not commenced

8,986

5,793

1,502

1,502

188

In addition to the table above, we have a contractual cost sharing obligation related to our collaboration agreement with Gilead for filgotinib. The contractual cost sharing commitment amounted to €602.8 million at 31 March 2020 for which we have direct purchase commitments of €25.8 million at 31 March 2020 reflected in the table above.

Contingent liabilities and assets

We refer to our Annual Report 2019 for a description of our contingent liabilities and assets.